The team led by Kari Alitalo report on the impact of transgenic or adeno-associated virus (AAV)-based VEGF-B overexpression on protection against acute myocardial infarction, signaling cascades, and metabolic sequelae. This evidence concerns the gene VEGFB and myocardial infarction.